Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

MDxHealth CEO Michael McGarrity Says We Expect To Reach The High End Of Our 2023 Revenue Guidance Of $65M-$70M, And Continue To Believe We Will Turn Profitable On An Adj. EBITDA Basis In H1 2025

Author: Benzinga Newsdesk | November 08, 2023 07:03pm

Posted In: MDXH